The new medication, a daily oral GLP-1 pill called orforglipron, which can promote weight loss in adults with obesity, demonstrates additional potential for adults who have both obesity and Type 2 diabetes
However, all these options require prescription injections, and many individuals do not meet the qualifying criteria
Because the right choice doesnt just reduce weightit restores life.
The 68-week STEP 1 trial showed 14.9% mean body weight reduction at 2.4mg, compared to retatrutide hitting 17.5% at just 24 weeks with the 12mg dose
310,311 GLP-1RAs also enhance autophagy, a process of cellular clearance of damaged and outdated components
As the research and development of retatrutide continue, the medical community remains cautiously optimistic about the future of this drug